T. Rowe Price Investment Management, Inc. - SELECT MED HLDGS CORP ownership

SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 214 filers reported holding SELECT MED HLDGS CORP in Q4 2022. The put-call ratio across all filers is 6.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of SELECT MED HLDGS CORP
ValueSharesWeighting
Q3 2023$154,610
-21.3%
6,118,306
-0.7%
0.11%
-18.7%
Q2 2023$196,389
+13.7%
6,164,109
-7.7%
0.13%
+8.1%
Q1 2023$172,697
+5.2%
6,680,734
+1.1%
0.12%
-1.6%
Q4 2022$164,123
-99.9%
6,609,861
+3.6%
0.13%
+11.5%
Q3 2022$140,976,0006,378,9720.11%
Other shareholders
SELECT MED HLDGS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Hillcrest Asset Management LLC 455,999$13,406,0002.04%
Smith, Graham & Co., Investment Advisors, LP 445,634$13,102,0001.30%
DENALI ADVISORS LLC 118,200$3,475,0001.30%
Huber Capital Management LLC 155,484$4,571,0001.20%
Sivik Global Healthcare LLC 90,000$2,646,0001.13%
Hood River Capital Management LLC 1,163,403$34,204,0001.02%
Phocas Financial Corp. 234,059$6,881,0000.88%
BOULDER HILL CAPITAL MANAGEMENT LP 18,600$547,0000.53%
Orbimed Advisors 1,233,600$36,268,0000.47%
FULLER & THALER ASSET MANAGEMENT, INC. 2,385,402$70,131,0000.41%
View complete list of SELECT MED HLDGS CORP shareholders